Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer

Por Niyongere, Sandrine, Saltos, Andreas, Gray, Jhanelle E.
Publicado no J Thorac Dis (2018)

Temporal trends in demographics and overall survival of non-small cell lung cancer patients at the Moffitt Cancer Center from 1986 to 2008

Por Schabath, Matthew B., Thompson, Zachary J., Gray, Jhanelle E.
Publicado no Cancer Control (2014)

Targeting Trop-2 in solid tumors: future prospects

Por Zaman, Saif, Jadid, Hassan, Denson, Aaron C, Gray, Jhanelle E
Publicado no Onco Targets Ther (2019)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer

Por Puri, Sonam, Lok, Benjamin H., Leighl, Natasha, Gray, Jhanelle E.
Publicado no Front Oncol (2020)

Tobacco-Related Health Disparities Across the Cancer Care Continuum

Por Simmons, Vani Nath, Piñeiro, Bárbara, Hooper, Monica Webb, Gray, Jhanelle E., Brandon, Thomas H.
Publicado no Cancer Control (2016)

Clinical associations of mucin 1 in human lung cancer and precancerous lesions

Por Saltos, Andreas, Khalil, Farah, Smith, Michelle, Li, Jiannong, Schell, Michael, Antonia, Scott J., Gray, Jhanelle E.
Publicado no Oncotarget (2018)

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial

Por Chen, Dung-Tsa, Schell, Michael J., Fulp, William J., Pettersson, Fredrik, Kim, Sungjune, Gray, Jhanelle E., Haura, Eric B.
Publicado no Transl Cancer Res (2019)

Novel Clinical and Radiomic Predictors of Rapid Disease Progression Phenotypes among Lung Cancer Patients Treated with Immunotherapy: An Early Report

Por Tunali, Ilke, Gray, Jhanelle E., Qi, Jin, Abdallah, Mahmoud, Jeong, Daniel K., Guvenis, Albert, Gillies, Robert J., Schabath, Matthew B.
Publicado no Lung Cancer (2019)

Phase II Randomized Study of Enzastaurin (LY317615) for Lung Cancer Prevention in Former Smokers

Por Gray, Jhanelle E., Altiok, Soner, Alexandrow, Mark G., Walsh, Frank W., Chen, Jian, Schell, Michael J., Tai, Datchen Fritz, Bepler, Gerold
Publicado em 2012

Strategies for power calculations in predictive biomarker studies in survival data

Por Chen, Dung-Tsa, Huang, Po-Yu, Lin, Hui-Yi, Haura, Eric B., Antonia, Scott J., Cress, W. Douglas, Gray, Jhanelle E.
Publicado no Oncotarget (2016)

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance

Por Creelan, Ben C., Gray, Jhanelle E., Tanvetyanon, Tawee, Chiappori, Alberto A., Yoshida, Takeshi, Schell, Michael J., Antonia, Scott J., Haura, Eric B.
Publicado no Br J Cancer (2019)

A Bayesian pick-the-winner design in a randomized phase II clinical trial

Por Chen, Dung-Tsa, Huang, Po-Yu, Lin, Hui-Yi, Chiappori, Alberto A., Gabrilovich, Dmitry I., Haura, Eric B., Antonia, Scott J., Gray, Jhanelle E.
Publicado no Oncotarget (2017)

TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer

Por Schabath, Matthew B., Giuliano, Anna R., Thompson, Zachary J., Amankwah, Ernest K., Gray, Jhanelle E., Fenstermacher, David A., Jonathan, Kristen A., Beg, Amer A., Haura, Eric B.
Publicado em 2013

Dual targeting of WEE1 and PLK1 by AZD1775 elicits single agent cellular anticancer activity

Por Wright, Gabriela, Golubeva, Volha, Remsing Rix, Lily L., Berndt, Norbert, Luo, Yunting, Ward, Grace A., Gray, Jhanelle E., Schonbrunn, Ernst, Lawrence, Harshani R., Monteiro, Alvaro N.A., Rix, Uwe
Publicado no ACS Chem Biol (2017)

Non-invasive decision support for NSCLC treatment using PET/CT radiomics

Por Mu, Wei, Jiang, Lei, Zhang, JianYuan, Shi, Yu, Gray, Jhanelle E., Tunali, Ilke, Gao, Chao, Sun, Yingying, Tian, Jie, Zhao, Xinming, Sun, Xilin, Gillies, Robert J., Schabath, Matthew B.
Publicado no Nat Commun (2020)

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small ce...

Por Chiappori, Alberto A., Williams, Charles C., Gray, Jhanelle E., Tanvetyanon, Tawee, Haura, Eric B., Creelan, Ben C., Thapa, Ram, Chen, Dung-Tsa, Simon, George R., Bepler, Gerold, Gabrilovich, Dmitry I., Antonia, Scott J.
Publicado no Cancer Immunol Immunother (2018)

PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer

Por Jhuraney, Ankita, Woods, Nicholas T., Wright, Gabriela, Rix, Lily, Kinose, Fumi, Kroeger, Jodi L., Remily-Wood, Elizabeth, Cress, W. Douglas, Koomen, John M., Brantley, Stephen G., Gray, Jhanelle E., Haura, Eric B., Rix, Uwe, Monteiro, Alvaro N.
Publicado no Mol Cancer Ther (2016)

Patient, Caregiver and Physician Perspectives on Participating in a Thoracic Rapid Tissue Donation Program

Por Quinn, Gwendolyn, Pentz, Rebecca D., Muñoz-Antonia, Teresita, Boyle, Theresa A., Schabath, Matthew B., Pratt, Christie, Shaffer, Andrea, Duarte, Luisa, Bowman-Curci, Meghan, Antonia, Scott, Chiappori, Alberto, Creelan, Benjamin, Gray, Jhanelle E., Williams, Charles, Haura, Eric
Publicado no Patient Educ Couns (2017)

A phase I, pharmacokinetic and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors

Por Gray, Jhanelle E., Haura, Eric, Chiappori, Alberto, Tanvetyanon, Tawee, Williams, Charles C., Pinder-Schenck, Mary, Kish, Julie A., Kreahling, Jenny, Lush, Richard, Neuger, Anthony, Tetteh, Leticia, Akar, Angela, Zhao, Xiuhua, Schell, Michael J., Bepler, Gerold, Altiok, Soner
Publicado em 2014

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Por Schabath, Matthew B, Dalvi, Tapashi B, Dai, Hongyue A, Crim, Alan L, Midha, Anita, Shire, Norah, Gimbrone, Nicholas T, Walker, Jill, Greenawalt, Danielle M, Lawrence, David, Rigas, James R, Brody, Robert, Potter, Danielle, Kumar, Naveen S, Huntsman, Shane A, Gray, Jhanelle E
Publicado no Cancer Manag Res (2019)